Press Release: Vanda : FDA Bureaucrats Unlawfully Delay Hearing on Vanda Drug and Falsely Blame Commissioner Makary and the reductions in force at FDA
WASHINGTON, April 23, 2025 /PRNewswire/ --Â Vanda Pharmaceuticals Inc. ("Vanda") (Nasdaq:...
Read full article »
President & CEO
Mihael H. Polymeropoulos
Vanda Pharmaceuticals develops and commercializes pharmaceutical products for the treatment of central nervous system disorders.
Read more